Advertisement
BWAY vs MBOT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Hold and MBOT is a Hold.
Momentum Indicator for BWAY turns negative, indicating new downward trend
BWAY saw its Momentum Indicator move below the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned negative. In 83 of the 100 cases, the stock moved further down in the following days. The odds of a decline are at 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 55 cases where BWAY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for BWAY entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BWAY's RSI Oscillator exited the oversold zone, 19 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for BWAY just turned positive on October 19, 2026. Looking at past instances where BWAY's MACD turned positive, the stock continued to rise in 38 of 50 cases over the following month. The odds of a continued upward trend are 76%.
Following a +5.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in 221 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
BWAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. BWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.813) is normal, around the industry mean (2.874). P/E Ratio (45.760) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (8.681) is also within normal values, averaging (40.124).
MBOT in -1.33% downward trend, declining for three consecutive days on October 21, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MBOT declined for three days, in 284 of 328 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Aroon Indicator for MBOT entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for MBOT just turned positive on October 22, 2026. Looking at past instances where MBOT's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.
MBOT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.918) is normal, around the industry mean (2.874). P/E Ratio (-3.768) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (263.158) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. MBOT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBOT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
BWAY | MBOT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 66 | 100 | |
SMR RATING 1..100 | 62 | 97 | |
PRICE GROWTH RATING 1..100 | 62 | 91 | |
P/E GROWTH RATING 1..100 | 65 | 9 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MBOT's Valuation (29) in the Biotechnology industry is somewhat better than the same rating for BWAY (86) in the Medical Specialties industry. This means that MBOT’s stock grew somewhat faster than BWAY’s over the last 12 months.
BWAY's Profit vs Risk Rating (66) in the Medical Specialties industry is somewhat better than the same rating for MBOT (100) in the Biotechnology industry. This means that BWAY’s stock grew somewhat faster than MBOT’s over the last 12 months.
BWAY's SMR Rating (62) in the Medical Specialties industry is somewhat better than the same rating for MBOT (97) in the Biotechnology industry. This means that BWAY’s stock grew somewhat faster than MBOT’s over the last 12 months.
BWAY's Price Growth Rating (62) in the Medical Specialties industry is in the same range as MBOT (91) in the Biotechnology industry. This means that BWAY’s stock grew similarly to MBOT’s over the last 12 months.
MBOT's P/E Growth Rating (9) in the Biotechnology industry is somewhat better than the same rating for BWAY (65) in the Medical Specialties industry. This means that MBOT’s stock grew somewhat faster than BWAY’s over the last 12 months.
| BWAY | MBOT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 78% | N/A |
| Momentum ODDS (%) | 2 days ago 83% | N/A |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 77% | 2 days ago 84% |
| Advances ODDS (%) | 4 days ago 84% | N/A |
| Declines ODDS (%) | 2 days ago 77% | 3 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 69% | 2 days ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BWAY’s FA Score shows that 0 FA rating(s) are green while MBOT’s FA Score has 2 green FA rating(s).
- BWAY’s FA Score: 0 green, 5 red.
- MBOT’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BWAY’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 3 bullish TA indicator(s).
- BWAY’s TA Score: 4 bullish, 4 bearish.
- MBOT’s TA Score: 3 bullish, 2 bearish.
Price Growth
BWAY (@Medical/Nursing Services) experienced а -3.21% price change this week, while MBOT (@Medical/Nursing Services) price change was -0.85% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.18%. For the same industry, the average monthly price growth was -9.32%, and the average quarterly price growth was -10.63%.
Reported Earning Dates
BWAY is expected to report earnings on Nov 10, 2026.
MBOT is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (+0.18% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
BWAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with DCTH. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then DCTH could also see price increases.
| Ticker / NAME | Correlation To BWAY | 1D Price Change % | ||
|---|---|---|---|---|
| BWAY | 100% | -4.51% | ||
| DCTH - BWAY | 33% Loosely correlated | +0.34% | ||
| ISRG - BWAY | 31% Poorly correlated | +3.67% | ||
| MBOT - BWAY | 30% Poorly correlated | +0.19% | ||
| ITGR - BWAY | 28% Poorly correlated | -0.11% | ||
| PLSE - BWAY | 27% Poorly correlated | +2.67% | ||
More | ||||